The U.S. Department of Justice’s (DOJ) lawsuit against Amedisys Inc. (NASDAQ: AMED) and UnitedHealth Group (NYSE: UNH) will ...

Amedisys (AMED) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook gives ...

UnitedHealth and Amedisys are heading to mediation with the Department of Justice over the DOJ’s bid to block their $3.3 billion merger over anticompetitive concerns. Late last week, Judge Susan ...

The Justice Department’s antitrust lawsuit aimed at blocking UnitedHealth Group’s $3.3 billion acquisition of Amedisys will go to mediation on Aug. 18. Magistrate Judge Susan Gauvey of the ...

The initiative will ensure Mercy Health employees have tuition benefit dollars in-hand prior to YSU’s tuition payment due ...

As funds are held back from the Ivy League and other leading universities, funding could be moved to public universities and ...

Terms apply to American Express benefits and offers. Visit americanexpress.com to learn more. Tracking your spending is often the first step to getting your finances in order. That can easily be ...

Patients in France will get immediate access through the “ATU framework” and is reimbursement expected to begin in Germany shortly. European approval is based on the completed phase 3 STR1VE ...

The United States Justice Department’s lawsuit to block UnitedHealth Group’s (UHG’s) $3.3 billion acquisition of Amedisys will head to mediation Aug. 18, according to court documents. Previously, a ...

The typical Georgia school will charge in-state undergraduates $6,466 in tuition and mandatory fees for two semesters next year. Tuition and fees will range from $3,506 at Swainsboro-based East ...

Home care providers in Pennsylvania are advocating for a 10% reimbursement rate increase to help address widespread direct care worker vacancies. “We understand that this is a challenging budget year, ...

However, Optum Health’s revenue was impacted by a rise in new patients who have lower reimbursement levels ... which seeks to block the subsidiary’s $3.3 billion purchase of Amedisys (Nasdaq: AMED).